Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: a population-based cohort study

Niamh Doherty* (Corresponding Author), Chris R Cardwell, Peter Murchie, Christopher Hill, Laurent Azoulay, Blánaid Hicks

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: a population-based cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences